Skip to content
Aminoscope
← Research
Peptides

How to Store Peptides: Shelf Life, Temperature, and Stability

Why lyophilized powder, refrigerated solution, and the enemies of stability decide whether your peptide is still the molecule you paid for.

Nadia Feldman6 min read
POTENCY RETAINEDTIME →Lyophilized, frozenPowder, fridgeMixed, room tempForm and temperature drive shelf life

How a peptide is stored decides whether the molecule you draw up months from now is the same molecule you paid for. Peptides are chains of amino acids held together by bonds that water, heat, light, and time can all break. The single most important variable is the physical form: a dry, freeze-dried powder behaves very differently from the same peptide once it is dissolved in liquid. This guide covers storage and stability only. If you need the mixing steps themselves, see our companion guide on how to reconstitute peptides; here we pick up the moment the vial arrives and follow it through to the point you discard it.

Lyophilized powder versus reconstituted solution

Most research peptides ship as a lyophilized (freeze-dried) powder. Removing water dramatically slows the chemical reactions that degrade a peptide, which is why dry formulations can remain stable for long periods when kept cold and sealed.[1] The trade-off arrives the instant you add diluent: in solution, hydrolysis, oxidation, and aggregation all accelerate, and shelf life collapses from months or years down to weeks. A study of lyophilized PTH(1-34), a 34-residue peptide closely comparable to the research peptides sold today, found the dry material far more durable than the same peptide once reconstituted, with measurable loss beginning soon after mixing.[2] Treat the two forms as two different products with two different clocks.

Recommended temperatures

For sealed lyophilized powder, refrigeration at 2–8°C (the standard pharmacy “refrigerated” range) is the everyday baseline, and a freezer extends the practical window further for vials you will not touch for weeks. Cold storage is what keeps the slow, residual degradation of a dry formulation slow.[1] Once reconstituted, the working rule is simple: refrigerate at 2–8°C and use within a few weeks. Approved peptide drugs make this explicit. The U.S. prescribing information for tesamorelin (Egrifta SV) directs patients to refrigerate the product and, once mixed, to inject it immediately rather than store the solution, because the reconstituted peptide is not designed to sit.[3] When an FDA-cleared peptide manufacturer with full stability data tells you to keep it cold, that instruction is the most reliable storage guidance available, and it generalizes well to research peptides that lack their own validated data.

The enemies of stability

Heat speeds every degradation reaction; leaving a vial in a warm car or near a window undoes the protection of cold storage. Light is a quieter threat: ultraviolet and even visible light drive oxidation, and light-induced oxidation of residues such as tryptophan can fragment the peptide backbone and create breakdown products that simply are not the molecule you intended to use.[4] Keep vials in their box or otherwise shielded from light. Repeated freeze–thaw is especially damaging to a peptide in solution; each cycle concentrates solutes and stresses the molecule, promoting aggregation, so a reconstituted vial should never be frozen and thawed repeatedly.[5] Agitation — shaking or rough transit — introduces air–liquid interfaces that encourage the same aggregation, which is one reason reconstitution calls for gentle swirling rather than vigorous shaking.

Bacteriostatic versus sterile water

The diluent you choose is also a storage decision. Sterile water contains no preservative, so a vial reconstituted with it should be treated as single-use or used very quickly. Bacteriostatic water contains roughly 0.9% benzyl alcohol, a preservative that suppresses microbial growth and is the reason a multi-dose vial can be entered repeatedly over a couple of weeks under refrigeration. Benzyl alcohol is not free, however: it can interact with some peptides and proteins and, in certain formulations, has been shown to promote aggregation.[6] The practical takeaway is to match diluent to use — bacteriostatic water for a vial you will draw from repeatedly, sterile water only when you intend to use the contents at once — and to remember that “preserved” protects against microbes, not against chemical degradation of the peptide itself.

Practical handling

Label every reconstituted vial with the date and concentration the moment you mix it; memory is not a stability strategy, and the date is what tells you when to stop using it. Return vials to the refrigerator promptly rather than leaving them on the counter between doses, and minimize the time spent at room temperature. For travel, a small insulated cooler with a cold pack keeps powder and solution in range, but avoid direct contact with ice, which can locally freeze and stress a reconstituted solution. When shipping or receiving, expect that cold-chain handling matters: lyophilized powder tolerates brief excursions far better than liquid, which is another reason most peptides ship dry.

Signs of degradation

Inspect every vial before use. A properly reconstituted peptide solution should be clear and colorless. Cloudiness, haze, visible particulates, floating flakes, or any color change are signs of aggregation, contamination, or breakdown, and the vial should be discarded rather than injected. Likewise discard anything past its labeled date, anything that was left warm for an extended period, or any reconstituted vial whose history you are unsure of. Degraded peptide is not just weaker; the breakdown products are unknown quantities.

The honest bottom line

Keep powder cold and dark, reconstitute only what you will use within a few weeks, refrigerate the solution, protect it from heat, light, freeze–thaw, and rough handling, label it with a date, and discard anything cloudy or expired. Most research peptides are not FDA-approved and carry no validated stability data of their own, so the conservative storage discipline drawn from approved peptide labels is the most defensible standard to follow.[3] This is general handling information, not medical or dosing advice.

Reviewed against primary sources by the Aminoscope desk

Sources

  1. [1] Qian KK, Grobelny PJ, Tyagi M, et al. (2015). Using the fluorescence red edge effect to assess the long-term stability of lyophilized protein formulations. Molecular Pharmaceutics. PMID 25786057
  2. [2] Merutka G, Murphy BM, Manning MC, et al. (2016). Stability of lyophilized teriparatide, PTH(1-34), after reconstitution. European Journal of Pharmaceutics and Biopharmaceutics. PMID 26620825
  3. [3] Theratechnologies Inc. (2024). EGRIFTA SV (tesamorelin for injection) — U.S. Prescribing Information: storage and reconstitution. DailyMed (U.S. National Library of Medicine). Source
  4. [4] Schöneich C. (2018). Novel chemical degradation pathways of proteins mediated by tryptophan oxidation: tryptophan side chain fragmentation. Journal of Pharmacy and Pharmacology. PMID 28134972
  5. [5] Tamura A, et al. (2023). Effect of chemical chaperones on the stability of proteins during heat- or freeze-thaw stress. International Journal of Molecular Sciences. PMID 37373447
  6. [6] Roy S, Jung R, Kerwin BA, et al. (2005). Effects of benzyl alcohol on aggregation of recombinant human interleukin-1-receptor antagonist in reconstituted lyophilized formulations. Journal of Pharmaceutical Sciences. PMID 15614819

Related tool

Peptide evidence matrix

See every peptide graded by how strong the human evidence actually is — filter by evidence tier, with a primary source on each grade.

More in Peptides